|Articles|October 13, 2015

Excelsior Medical Corporation is Sold to ICU Medical, Inc.

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announces the sale of Excelsior Medical Corporation to ICU Medical, Inc. ICU Medical develops, manufactures and sells medical technologies used in infusion therapy, oncology and critical care applications.
  
Excelsior, based in Neptune, N.J., is a leading provider of intraluminal catheter care and disinfection products. The company's goal is to help clinicians reduce the risk of infection, avoid medication errors and lower healthcare costs. Excelsior has developed and commercialized the innovative SwabCap® and SwabFlush™ products, and is a leader in pre-filled saline and heparin flush syringes. The company also manufactures and sells pharmacy filling and syringe infusion pump and tubing systems. In connection with this transaction, ICU Medical has agreed to sell the pre-filled syringe and SwabFlush™ businesses to Medline Industries, Inc. ICU Medical will retain the SwabCap® and pumps and tubing businesses.
  
"Excelsior's management team has done an excellent job of building a fully-integrated platform in intraluminal catheter care," says Lester B. Knight, founding partner of RoundTable and chairman of Excelsior. "We believe that ICU Medical and Medline will be strong strategic partners for the company, its employees, and customers going forward."
  
Steve Thornton, CEO of Excelsior Medical Corporation, says, "RoundTable has been a tremendous partner for Excelsior since their initial acquisition of the Company in 2004. They have provided key access to customers and helped expand our product offerings. We look forward to partnering with ICU Medical and Medline to continue to achieve our growth objectives."
  
Robert W. Baird & Co. acted as exclusive financial advisor to Excelsior Medical Corporation and Sidley Austin LLP acted as exclusive legal advisor to RoundTable in this transaction.
  
Source: RoundTable Healthcare Partners


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.